A Targeted Approach to HealthCare

Bayer HealthCare Pharmaceutical's goal is to discover products that will improve human health worldwide by diagnosing, preventing and treating diseases. As a specialty pharmaceutical company, we focus our efforts where we can have the most impact.

For more than 100 years, Bayer has been dedicated to developing, manufacturing and marketing pharmaceuticals. Built on the company's long history of providing medicines that healthcare providers and patients can trust, Bayer is one of the most recognized brands in health care.

Bayer News Releases

---

2 July 2008 - Bayer News Releases Bayer HealthCare acquires hematology development portfolio featuring MAXY-VII from Maxygen more

24 June 2008 - Bayer News Releases Bayer concludes supply and licensing agreements for Yasmin® and YAZ® with Barr for the United States more

5 June 2008 - Bayer News Releases Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients more

28 May 2008 - Bayer News Releases Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals more

19 May 2008 - Bayer News Releases Hemophilia Awareness and Fundraising Program Accelerates more

19 May 2008 - Bayer News Releases Bayer Announces Availability of Reformulated Liquid Leukine® more

30 April 2008 - Bayer News Releases Fashion Guru Nina Garcia Launches National Design Competition more

31 March 2008 - Bayer News Releases Bayer appeals invalidity ruling on its Yasmin® Patent more

11 March 2008 - Bayer News Releases Bayer HealthCare Pharmaceuticals Introduces VistaTrak™ An Innovative Contrast Media Management System more

3 March 2008 - Bayer News Releases Court decides against Bayer's Yasmin® patent more

18 February 2008 - Bayer News Releases Bayer and Onyx Provide Update on Phase 3 Trial of Nexavar in Patients with Non-Small Cell Lung Cancer more

5 February 2008 - Bayer News Releases Bayer HealthCare Awards Grant to Support Future Leaders of Bleeding Disorders Community more

23 January 2008 - Bayer News Releases Bayer Establishes US Special Access Program for Leukine® While Replacing Current Liquid Formulation more